Universite DES Sciences, DES Techniques Et DES Technologies De Bamako (Usttb)

Universite DES Sciences, DES Techniques Et DES Technologies De Bamako (Usttb), doing business as University Of Sciences, Techniques And Technologies Of Bamako, is a not-for-profit academic institution headquartered in Bamako, Mali, that functions as a research grant recipient and occasional contract performer for U.S. federal agencies studying infectious disease, public health, and cancer prevention in West Africa. The institution operates as a prime recipient on 83 of 97 recent awards (86%) and acts as a sub-recipient on 14 awards, competing under full-and-open federal grant mechanisms without set-asides.

USTTB's federal footprint centers almost entirely on the National Institute of Allergy and Infectious Diseases (NIAID), which accounts for 54 awards and $68.5 million in combined potential value—approximately 79% of USTTB's recent award portfolio. The next-largest customer is NIAID's Designated Extramural Activities Acquisitions office (16 awards, $17.3 million), followed by the Fogarty International Center, National Cancer Institute, and National Institute of Neurological Disorders and Stroke, together accounting for the remaining 20% of capacity. Across customer agencies, USTTB has served 13 distinct NIH and HHS offices since 2007. The dollar concentration with NIAID is stark: the top two customer lines control $85.8 million of the $86.9 million combined portfolio, leaving minimal diversification.

USTTB's concrete capability portfolio centers on scientific, technical, logistical, and administrative support services for U.S.-funded infectious disease research conducted in Mali under NIAID's International Centers for Excellence in Research (ICER) program. Representative work includes a $8.8 million delivery-order ceiling through November 2027 (awarded December 2024) for ICER Mali support services; a $1.2 million prior delivery order (July 2024) for the same program; and a $1.6 million award (February 2022) for ICER research platform operations. Beyond ICER contract delivery orders, USTTB holds prime status on multiple NIH research grants. Recent grant recipients roles include a $293,500 NIAID Project Grant (September 2025, CFDA 93.855) investigating dengue fever epidemiology and risk factors in urban and rural Mali; a $400,000 USAID Cooperative Agreement (November 2024, CFDA 98.001) for entomological surveillance, insecticide-treated bed net durability monitoring, and antimalarial drug efficacy surveillance; a Fogarty International Center cooperative agreement (September 2026) supporting a five-year West Africa implementation research platform for elimination of neglected tropical diseases; and a National Cancer Institute Project Grant (August 2026) for a Mali–Northwestern University breast cancer prevention research training program including PhD and master's-level epidemiology and pathology training at USTTB. USTTB also hosts a West Africa Center of Excellence for Data Science Research Education (cooperative agreement, September 2023, ultimate completion May 2027) in partnership with Tulane University and Gamal Abdel Nasser University of Conakry, Guinea, focused on building capacity in quantitative and analytical approaches to large infectious disease datasets.

USTTB subcontracts to larger U.S. research institutions in support of multi-country West Africa research programs. Named prime grantees include Northwestern University (multiple sub-awards in cervical cancer prevention research, cancer research training, and tuberculosis/HIV diagnostics), Columbia University (training and mentoring in virome capture sequencing and molecular biology curricula), George Washington University (U.S.–Mali research ethics training and non-communicable disease risk-factor research capacity enhancement), and University of Maryland Baltimore (genomic surveillance for antimalarial drug resistance). Sub-recipient work typically involves training, laboratory operations, field surveillance coordination, and curriculum support in partnership with U.S. university-led research programs.

USTTB's activity shows volatility: five prime awards in 2022, three in 2023, eight in 2024, four in 2025, and seven in 2026. Nine awards (combined potential value $9.4 million) reach ultimate completion within the next twenty-four months, creating near-term recompete exposure. Service Contract Inventory data show minimal scale: $2.8 million in SCI-reported invoiced revenue in FY2023 (286 FTEs at contract level), with no SCI-reportable revenue in FY2022, FY2024, or FY2025. The FY2023 spike reflects a single large ICER delivery-order contract; SCI-based hourly rates ranged from $4.53/hr (10th percentile) to $5.32/hr (90th percentile), reflecting the substantial in-country labor cost structure of a Malian institution. USTTB does not typically subcontract to other vendors; across SCI prime records, the average subcontractor hours share is 0%, indicating the institution delivers most services through its own staff.